| PUBCHEM ID |
109374136
|
| UNII |
J7G35Q0IAW
|
| Preferred Term |
N-DESMETHYL-N-CYCLOPENTYL CIS-TADALAFIL
|
| CAS |
171488-19-0
|
| INCHIKEY |
PWUCUSITNKSTMS-NBGIEHNGSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
O=C(CN(C1CCCC1)C([C@@H]1Cc2c3[nH]c4c2cccc4)=O)N1[C@@H]3c(cc1)cc2c1OCO2
|
| Total Surface Area |
313,11
|
| Relative PSA |
0,21453
|
| TPSA |
74,87
|
| cLogS |
-4,914
|
| MW |
443,502
|
| cLogP |
3,6097
|
| H-Acceptors |
7
|
| H-Donors |
1
|
| Ro5 violations |
0
|
| Druglikeness |
2,5498
|
| DrugScore |
0,548971975176125
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,7902
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Inhibitor
|
| CYP450 3A4 Inhibitor |
Inhibitor
|
| CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,2283
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,3019
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,3804
|
| Carcinogenicity (Three-class) |
Non-required
|
